You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MAB 124I-omburtamab

Showing 51 - 75 of 306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)

Active, not recruiting
  • Advanced Malignancies
  • Non-small-cell Lung Cancer
  • Beijing, Beijing, China
  • +51 more
Jan 11, 2023

Asthma Trial in Montpellier, Tours (blood sample)

Not yet recruiting
  • Asthma
  • blood sample
  • Montpellier, France
  • +1 more
Aug 10, 2022

HIV Trial in Worldwide (VRC01, Placebo for VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Birmingham, Alabama
  • +25 more
Feb 8, 2022

Metastatic Differentiated Thyroid Cancer Trial in Negrar, Milan (Radioiodine optimized therapy)

Recruiting
  • Metastatic Differentiated Thyroid Cancer
  • Radioiodine optimized therapy
  • Negrar, Verona, Italy
  • +1 more
Mar 18, 2022

Relapsing Multiple Sclerosis Trial in Puerto Rico, United States (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Birmingham, Alabama
  • +16 more
Mar 22, 2022

Multiple Sclerosis Trial (Natalizumab)

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Jun 21, 2023

SARS-CoV-2 Infection Trial in Houston (S-217622, Placebo)

Recruiting
  • SARS-CoV-2 Infection
  • Houston, Texas
    Accurate Clinical Management, LLC
Aug 10, 2022

Hemorrhagic Fever, Ebola Trial in Congo, The Democratic Republic of the, Sierra Leone (Ansuvimab)

Available
  • Hemorrhagic Fever, Ebola
  • Mbandaka, Equateur, Congo, The Democratic Republic of the
  • +3 more
May 3, 2022

Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

Recruiting
  • Advanced Lung Carcinoma
  • +16 more
  • Anti-CTLA4 Monoclonal Antibody BMS-986218
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Solid Tumor, Adult Trial in Belgium, France (BI 765063, BI 754091)

Recruiting
  • Solid Tumor, Adult
  • BI 765063
  • BI 754091
  • Brussels, Belgium
  • +6 more
Dec 20, 2021

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-MAB)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jan 24, 2022

Systemic Amyloidosis Trial in Knoxville (124I-p5+14 Injection)

Completed
  • Systemic Amyloidosis
  • 124I-p5+14 Injection
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Mar 23, 2022

Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

Not yet recruiting
  • Allergic Rhinitis
  • Conjunctivitis
  • (no location specified)
Jun 20, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Advanced Gastric Cancer Trial in Boston, Dallas, Fairfax (IMM2902)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

HIV Trial in Worldwide (VRC01, Placebo for VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Gaborone, South-East District, Botswana
  • +20 more
Feb 8, 2022

Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival Trial in Wuhan (Surufatinib)

Recruiting
  • Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival
  • Wuhan, Hubei, China
    Zhongnan Hopital of Wuhan University
Mar 8, 2022

Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh

Recruiting
  • Recurrent Head and Neck Cancer
  • Carcinoma, Squamous Cell of Head and Neck
  • Baltimore, Maryland
  • +3 more
Mar 25, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +67 more
Jul 26, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Diffuse Cutaneous Systemic Sclerosis Trial in United States (TEPEZZA, Placebo)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • TEPEZZA
  • Placebo
  • Los Angeles, California
  • +6 more
Jul 22, 2022

Advanced Solid Tumor or Lymphoma Trial in United States (BJ-005)

Recruiting
  • Advanced Solid Tumor or Lymphoma
  • BJ-005
  • Phoenix, Arizona
  • +5 more
Jul 19, 2022

Neuroblastoma Trial in San Francisco (124I-Metaiodobenzylguanidine (MIBG) (no-carrier added), 124I-MIBG (carrier added),

Terminated
  • Neuroblastoma
  • 124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)
  • +2 more
  • San Francisco, California
    University of California, San Francisco
May 12, 2021

Migraine Trial in Los Angeles, Newport Beach, Waterbury (Galcanezumab, Erenumab)

Completed
Has Results
  • Migraine
  • Los Angeles, California
  • +2 more
Feb 23, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Plasmodium Falciparum Infection, Malaria Trial in Kalifabougou, Torodo (L9LS (VRC-MALMAB0114-00-AB), Normal saline)

Recruiting
  • Plasmodium Falciparum Infection
  • Malaria
  • L9LS (VRC-MALMAB0114-00-AB)
  • Normal saline
  • Kalifabougou, Région De Koulikoro, Mali
  • +1 more
Apr 7, 2022